Kathy Hodgkinson and Daryl Pullman propose that high risk/high recurrence genetic diseases should come under the purview of public health.

Françoise Baylis responds to the recently announced birth of the world’s first genome edited babies and raises concerns about the scientific practice and ethical accountability.

Deborah Gleeson and Ronald Labonté object to lengthening market exclusivity for biologic medicines in the United States-Mexico-Canada Agreement.

Jason Scott Robert suggests that the creation of part-human animals in stem cell biology may generate scientific confusion.

Yeyang Su invites Impact Ethics readers to mark their calendars for the second International Summit on Human Genome Editing.

Françoise Baylis supports the proposed new regulations for reimbursement related to assisted human reproduction.

Landon J. Getz provides an update on Canadian Blood Services’ progress in updating outmoded policies on gay blood donation.